Naspers has made a positive break by breaking upwards through the down sloping resistance line at ZAR1700.00 and could potentially test ZAR2500.00. Prosus has given a positive break by breaking upwards through the downwards sloping resistance line at ZAR850.00 and could potentially test ZAR1080.00 to ZAR1160.00. Mediclinic has broken upwards out of its medium-term bull channel and has also breached a medium-term resistance line at ZAR80.00. The most recent positive move was triggered by a buyout offer for the remaining shares in issue by a consortium consisting of Remgro and MSC Mediterranean Shipping Company. Technically the share can potentially test ZAR97.70 in our view.
This report provides technical analyses of Naspers (NPN), Prosus (PRX), and Mediclinic (MEI).
